Jul 31, 2012 7:35am EDT

22nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels

Jul 09, 2012 8:01am EDT

Chinese and Australian Patents Allowed for 22nd Century’s NBB Nicotine Biosynthesis Gene

May 16, 2012 6:22am EDT

22nd Century Group Closes Financing and Reports First Quarter Financial Results

Apr 17, 2012 6:45am EDT

22nd Century Group Files Annual Report and Provides Business Update

Apr 10, 2012 9:12am EDT

22nd Century Group to File Modified Risk Cigarette Applications with the FDA

Feb 08, 2012 7:22am EST

22nd Century Announces Nicotine-Free Tobacco Cigarettes Now Available For International Markets

Dec 26, 2011 4:17pm EST

22nd Century Group Announces Initial Results of Smoking Cessation Trial

Sep 27, 2011 7:00am EDT

Enrollment Completed in 22nd Century’s X-22 Phase II-B Clinical Trial

Sep 20, 2011 11:29am EDT

22nd Century Delivers Proprietary Research Cigarettes for U.S. Government Order

Sep 08, 2011 1:46pm EDT

22nd Century Group to Present at the Rodman & Renshaw Global Investment Conference